FDA Warns Against DMagic Plus Due to Hidden Harmful Ingredients
On August 12, 2026, the Food and Drug Administration (FDA) advised consumers against purchasing or using DMagic Plus, a product marketed for weight loss on various websites, including www.lamilagrosalab.com, and possibly available in some retail locations. The FDA's laboratory analysis confirmed that DMagic Plus contains diclofenac, neriifolin, and thevetin B, none of which are disclosed on the product label. Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that can elevate the risk of serious cardiovascular issues, such as heart attacks and strokes, and may also cause significant gastrointestinal problems, including bleeding, ulcers, or potentially life-threatening tears in the stomach or intestines. Furthermore, diclofenac can interact dangerously with other medications, particularly other NSAIDs, increasing the likelihood of severe side effects. Neriifolin and thevetin B, derived from the yellow oleander plant (Thevetia peruviana), are associated with severe neurological, gastrointestinal, and cardiovascular adverse health effects, which can be fatal. The FDA encourages both healthcare professionals and consumers to report any adverse events or side effects related to DMagic Plus to the FDA's MedWatch Safety Information and Adverse Event Reporting Program. This notification aims to raise awareness about products that may be marketed as dietary supplements or conventional foods but contain hidden drug ingredients and chemicals. Such products are often promoted for weight loss, sexual enhancement, pain relief, and bodybuilding, falsely claiming to be all-natural. The FDA urges consumers to exercise caution when considering these products, as it cannot test and identify all dietary supplements that may contain harmful hidden ingredients.




